UNIVERSITY PARK, Pa. â€” A new liquid-cell technology allows scientists to see living biological materials and systems in three dimensions under an electron microscope, according to researchers at Penn State, Virginia Tech and Protochips Inc.
â€œWith this technology that we developed in collaboration with Protochips, scientists could analyze host-pathogen interactions, see a virus being introduced into a cell and watch molecular mechanisms take place in real time,â€� says Deb Kelly, professor of biomedical engineering. â€œThe work represents the worldâ€™s first nanoscale CAT scan in a liquid environment.â€�
In a cover article appearing in Nano Letters, Kelly and colleagues report new insights into bacteriophage and host bacterium interactions that could in the future lead to methods to kill antibiotic-resistant bacteria. Their images revealed structural features of the bacteriophage that were previously not well understood.
The field of liquid-cell electron microscopy has grown rapidly in recent years, but until now it has been limited to 2D. In tomography, slices of a sample are imaged as the sample is tilted. Then, the images are stacked into 3D using computer software.
â€œWe use a copper grid that is coated with a carbon layer and cover that with a silicon nitride chip,â€� says lead author William Dearnaley, who is the technical director in Kellyâ€™s Center for Structural Oncology. â€œThere is a window in the chip and we pipette the liquid sample in between the two layers.â€�
This chip design fits into any type of microscope holder, so it can be universally adapted for any material. The researchers expect the technique will be widely adopted in both life sciences and in materials science, for instance in battery research or to look at defects causing building materials to fail.
â€œEventually, we want to see drugs targeting cancer cells,â€� Kelly says.
Additional authors on the paper, titled “Liquid-Cell Electron tomography of Biological Systems,” are assistant professor Cameron Varano, assistant research professor and Nick Alden, graduate student, both in biomedical engineering at Penn State, and Floricel Gonzalez, graduate student in biomedical engineering at Virginia Tech. Michael Cassanta, post-doctoral scholar at Penn State, and Birgit Scharf, professor of biological sciences and a phage expert at Virginia Tech, made essential scientific contributions to the project. Data analysis and experimental design elements for the work were provided by Madeline Dukes, Protochips Inc, and Beatrice Schleupner, a former high school student at the Roanoke Valley Governorâ€™s School for Science and Technology, now at Duke University.
The National Institutes of Health’s National Cancer Institute supported this work.